We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Bruker Daltonics Logo

Bruker Daltonics

Bruker Daltonics is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Their high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.

Latest Bruker Daltonics Content

Scientist with an assay plate.
Product News

Bruker Launches Transformative neofleX ™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) announced the launch of a novel, high-performance MALDI-TOF/TOF system, the neofleX Imaging Profiler for mass spectrometry-based tissue imaging.
Cells.
Product News

Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 To Enable New Research Paradigms in Single-Cell and Subcellular Proteomics

At the 72nd ASMS meeting, Bruker Corporation (Nasdaq: BRKR) launches the new top-of-the-line timsTOF Ultra 2 system with significantly further enhanced sensitivity for deep profiling of small cells and subcellular organelles.
The entrance to Bruker’s new production facility in Bremen, Germany.
Industry Insight

Bruker Unveils New, Sustainable Manufacturing Facility in Bremen

Bruker Corporation officially opened its new production facility in Bremen – one of Germany’s major science hubs – last week. Technology Networks visited the facility to learn about its low carbon footprint and how it will support Bruker's commitment to innovation and collaboration.
Cartoon of two scientists in a lab.
Product News

Bruker Showcases High-Performance Solutions at Analytica 2024 for Research and Analysis

Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024.
TechnologyNetworks_Webinar_Bruker_Event_May8,2024
Webinar

Next-Generation Plasma Lipidomics: Quantification With dia-PASEF

On-Demand
Human blood plasma contains thousands of distinct lipid species. These lipids can provide new insights into health and disease, with lipidomic profiling revealing new biomarkers for various conditions and being used to monitor the efficacy of treatments.
Immunopeptidomics
eBook

Immunopeptidomics With TIMS and PASEF

In this eBook, expert insights reveal how to detect these elusive targets with TIMS and PASEF for unmatched sensitivity, precise precursor control and deeper MHC insights.
Child drinking tap water from a reusable water bottle.
Article

Improved Persistent Organic Pollutants Analysis for a Safer Global Environment

Persistent organic pollutants (POPs) are toxic chemicals that threaten human health and cause environmental deterioration. This article highlights the potential of trapped ion mobility spectrometry (TIMS) for improved POPs analysis.
BrukerWebinarApril30th2024_HostedbyTechnologyNetworks
Webinar

Multiplex Multiomics: The Future of Spatial Biology in Cancer Research

On-Demand
Join this webinar to discover how to integrate spatial biology and multiomics approaches to reveal the intricate interactions between cancer cells and their environment.
BrukerCanopyWebinar_March21,2024_HostedByTechnologyNetworks
Webinar

Accelerating the Screening of Seized Drugs With Chromatography-Free Workflows

On-Demand
Attend this webinar to discover how direct analysis in real time (DART), in combination with high-resolution mass spectrometry (HRMS), allows the generation of reliable analytical results much faster and easier than alternative techniques.
Blue and red lipid bilayer.
Article

Bringing the Benefits of 4D-Lipidomics Research to the Clinic

The capabilities of trapped ion mobility spectrometry combined with automated data annotation software are driving new developments in lipid analysis. This article discusses how such advances are bringing the technology to more mainstream use, setting the foundations for future clinical research.
Advertisement